Melanoma In Situ — Trials

Melanoma In Situ — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1
Recruiting: 1
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Institute of Health Information and Statistics of the Czech Republic
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03233828	Pre-Treatment of Highly Suspicious Pigmented Skin Lesions With Interleukin-2(IL-2)	terminated	Phase 3	1	Carman GiacomantonioOTHER	1	Jul 24, 2024	clinicaltrials

Data updated 22 days agoSource updated Jul 24, 2024source: clinicaltrials